← Back to all trials
Completed
NCT06952647
Hematological Markers in Idiopathic Carpal Tunnel Syndrome
Conditions: Carpal Tunnel Syndrome (CTS), Biomarkers / Blood
Sex: All
Ages: 18 Years – 65 Years
Healthy volunteers: Yes
Enrollment: 197
Sponsor: Ankara Training and Research Hospital
Location: Department of Physical Therapy and Rehabilitation, University of Health Sciences, Ankara Training and Research Hospital Ankara Altindag
Summary
Carpal Tunnel Syndrome (CTS) cases are still classified as idiopathic. The rationale of this research is to investigate the role of chronic inflammation and vitamin B12 deficiency in the onset and severity of idiopathic CTS. This case-control study aims to evaluate inflammatory hematological markers and vitamin B12 levels in patients with idiopathic CTS compared to healthy controls, and to analyze their correlation with clinical and electrophysiological severity of the disease
Eligibility Criteria
Inclusion Criteria:
* Age between 18-65 years
* Having undergone Electromyography (EMG) testing for Carpal Tunnel Syndrome (CTS)-like symptoms
* Recent complete blood count, C-Reactive Protein (CRP), and albumin available
Exclusion Criteria:
* Age below 18 or above 65 years
* Pregnancy
* History of wrist trauma or surgical operation
* Chronic kidney disease
* Gout
* Rheumatoid arthritis
* Connective tissue disease
* Thyroid disorders
* Acromegaly
* Polyneuropathy
* Thoracic outlet syndrome
* Brachial plexopathy
* Cervical disc herniation
* Presence of cardiac pacemaker
* Steroid use
Source: ClinicalTrials.gov (NCT06952647). StuddyBuddy aggregates publicly available trial information.